mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Clinical trial NCT05918250 · WITHDRAWN

Trial details

NCT number: NCT05918250
Sponsor: ModernaTX, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma

Start date: 2023-08-15
Primary completion: 2026-05-27
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.